Managing Advanced Renal Cell Carcinoma - Quinn

David Quinn, MD, on best utilization of stereotactic radiation in the management of aRCC patientsПодробнее

David Quinn, MD, discusses Checkmate-214 investigating nivolumab + ipilimumab in aRCC patientsПодробнее

David Quinn, MD, describes if biomarkers help guide treatment in advanced renal cell carcinomaПодробнее

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCCПодробнее

Toxicity Management in Advanced Renal Cell Carcinoma: Immunotherapy InsightsПодробнее

Kidney Cancer Surgery: A Step Towards Healing and Hope!Подробнее

Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell CarcinomaПодробнее

Advanced renal cell carcinoma: Managing long term durable responseПодробнее

David Quinn, MD, on impressions of the oral inhibitor study in renal cell carcinoma patientsПодробнее

Surgical Management of Locally Advanced Renal Cell Carcinoma - Christopher Wood, M.D.Подробнее

Guidelines Based Management of Localized and Locally Advanced RCCПодробнее

Current Treatment of advanced renal cell carcinoma, Christian Kollmannsberger, MDПодробнее

Managing Untreated, Metastatic Renal Cell CarcinomaПодробнее

Dr. Quinn on the Future of Treatments for RCCПодробнее

Managing renal cell carcinoma after progressing on checkpoint inhibitorsПодробнее

Advanced renal cell carcinoma treatmentПодробнее

Goals of Therapy for Advanced Kidney CancerПодробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Managing Renal Cell Carcinoma ProgressionПодробнее